Archives

How Employers Can Save $550/Month on GLP-1s: Introducing Vida Self-Pay

What You Should Know – Vida Health has partnered with RxSaveCard to launch Vida Self-Pay, a first-of-its-kind platform that bypasses traditional PBM markups for anti-obesity medications (AOMs). – By combining virtual, whole-person clinical care with transparent “cash-price” subsidies, the partnership enables employers to save up to $550 per member per month while expanding access to […]

Ozempic’s unexpected side effect: saving airlines $580 million a year on fuel

A new financial report claims weight loss drugs like Ozempic and Wegovy could deliver an unexpected beneficiary: the airline industry. According to a study from investment firm Jefferies, widespread use of GLP-1 medications could reduce average passenger weight enough to meaningfully cut fuel costs, potentially saving major U.S. airlines hundreds of millions of dollars each […]

CoreAge Rx Expands GLP-1 Access to Support New Year Weight Loss Goals

WICHITA FALLS, Texas, Jan. 20, 2026 /PRNewswire/ — CoreAge Rx, a leading telehealth pharmacy specializing in personalized medication services, today announced a strategic New Year’s expansion of its compounded GLP-1 weight management program. The expansion provides increased access to…

Zaidy’s owner, weight loss doctor introduce product to combat ‘Ozempic face’

Low energy. “Ozempic face.” Feeling like a deflated balloon. They can be the downsides for people on GLP-1s, the increasingly popular drugs that go by the names Ozemic, Wegovy and Mounjaro. But Joel Appel and Dr. Michael Snyder say that can be addressed through proper nutrition, which can fall by the wayside when the drugs […]

Bariatric surgery beats GLP-1s for type 2 diabetes across income levels, study says – statnews.com

Bariatric surgery beats GLP-1s for type 2 diabetes across income levels, study says  statnews.com Northwest Health Offers Seminar about Weight Loss Surgery and GLP-1a  greatnews.life Bariatric surgery reshapes body fat and muscle more than GLP-1 drugs  News-Medical Can Social Factors Derail Bariatric Gains?  Conexiant Weight-Loss Surgery or GLP-1s? Both Offer Sustained Fat Loss  Medscape

Bariatric surgery outpaces GLP-1s for diabetes, SDOH: Study

In a review of 258 patients with Type 2 diabetes who underwent metabolic bariatric surgery or medical and lifestyle interventions, including GLP-1 drugs, surgery was superior regardless of social determinants of health.  The research, published Jan. 20 in Annals of Internal Medicine, pulls from randomized clinical trials conducted across four U.S. academic medical centers. These […]

Is Oral Wegovy a Game Changer for Novo Nordisk?

Key Points Novo Nordisk just launched an oral version of its popular weight-loss therapy, Wegovy. This move might help it make some headway in an increasingly competitive market. However, Eli Lilly is close to launching its own oral weight management medicine. 10 stocks we like better than Novo Nordisk › Novo Nordisk (NYSE: NVO) was […]

What Happened to Viking Therapeutics in 2025, And Is it a Buy for 2026?

Key Points Viking Therapeutics’ stock was volatile in 2025 due to clinical trial results. VK2735’s oral form faced safety concerns but remains promising. Viking could be an acquisition target given its cash and drug pipeline. 10 stocks we like better than Viking Therapeutics › Investors in biotechnology company Viking Therapeutics (NASDAQ: VKTX) had a rollercoaster […]